NCI | Technology Transfer

HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation

Read more about HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation

Singapore
11202300142Y
Filed on 2023-01-06

HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation

Read more about HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation

South Korea
10-2023-7004523
Filed on 2023-02-08

HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation

Read more about HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation

China
202180061706.7
Filed on 2023-03-08

HLA Class-II Restricted DRB T-cell Receptors Against RAS with G12D Mutation

Read more about HLA Class-II Restricted DRB T-cell Receptors Against RAS with G12D Mutation

Australia
2021310213
Filed on 2023-02-03

HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation

Read more about HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation

Canada
3185241
Filed on 2023-01-06

HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12D
MUTATION

Read more about HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION

Japan
2023-502572
Filed on 2023-01-12

METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR-REACTIVE T CELLS FROM TUMOR

Read more about METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR-REACTIVE T CELLS FROM TUMOR

US Application 18/093,902
Filed on 2023-01-06

Combination Immunotherapy Compositions And Methods

Read more about Combination Immunotherapy Compositions And Methods

US Patent 11,590,216
Filed on 2020-12-22

Combination Immunotherapy Compositions And Methods

Read more about Combination Immunotherapy Compositions And Methods

US Patent 11,596,675
Filed on 2020-11-18

Viral Methods Of T Cell Therapy

Read more about Viral Methods Of T Cell Therapy

Japan
2022-185536
Filed on 2022-11-21

Subscribe to NCI